05 April, 2024 Uncategorized Pantherna and WACKER Intensify Collaboration in the Development and Production of mRNA Biopharmaceuticals
25 October, 2023 Allgemein New article alert: “Cationic LNP-formulated mRNA expressing Tie2-agonist in the lung endothelium prevents pulmonary vascular leakage”.
11 October, 2023 Allgemein New article alert: “The PTXΔLNP® Platform: On the Promise of Developing New LNPs for Tomorrow’s mRNA Therapies”.
07 June, 2023 Allgemein Pantherna Therapeutics teams up with University Medicine Rostock (UMR) on exploring new opportunities for mRNA therapy in ocular disease
04 October, 2022 Allgemein Astellas and Pantherna Enter into a New Technology Evaluation Agreement for Research with Expanded Target Organ to Generate mRNA-Based Regenerative Medicine Programs Using Direct Reprogramming
05 September, 2022 Allgemein Pantherna Therapeutics collaborates with Charité – Universitätsmedizin Berlin to investigate the potential of therapeutic mRNA in autoimmune disease